Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01625260
Title A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Altor Bioscience Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 United States Details
University of California Davis Sacramento California 95817 United States Details
UF Health Center at Orlando Health Orlando Florida 32806 United States Details
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 United States Details
UPMC Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field